Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry

Forensic Toxicology

Volumn 31, Issue 2, 2013, Pages 241-250

  Nakazono, Yukiko ^a,c   Tsujikawa, Kenji ^a   Kuwayama, Kenji ^a   Kanamori, Tatsuyuki ^a   Iwata, Yuko T ^a   Miyamoto, Kazuna ^b,c   Kasuya, Fumiyo ^b   Inoue, Hiroyuki ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c Hitec Inc   (Japan)

Author keywords

Designer drug; Fluoroamphetamine analogs; GC MS; LC MS; Regioisomer

Indexed keywords

ACETIC ACID DERIVATIVE; AMPHETAMINE DERIVATIVE; FLUOROAMPHETAMINE DERIVATIVE; FLUOROMETHAMPHETAMINE DERIVATIVE; TRIFLUOROACETYL DERIVATIVE; TRIMETHYLSILYL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ELUTION; ISOMER; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SYNTHESIS; TANDEM MASS SPECTROMETRY;

EID: 84879797084     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-013-0184-7     Document Type: Article

References (20)

1. Namera A, Nakamoto A, Saito T, Nagao M (2011) Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review. Forensic Toxicol 29:1-24
2. Zaitsu K, Katagi M, Tatsuno M, Sato T, Tsuchihashi H, Suzuki K (2011) Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis. Forensic Toxicol 29:73-84
3. Nakajima J, Takahashi M, Seto T, Yoshida M, Kanai C, Suzuki J, Hamano T (2012) Identification and quantification of two new naphthoylindole drugs-of-Abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalene-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalene-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo area. Forensic Toxicol 30:33-44
4. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2012) Identification of two new-type synthetic cannabinoids, N-(1-Adamantyl)-1-pentyl-1H-indole-3- carboxamide (APICA) and N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13(CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol 30:114-125
5. Fuller RW, Baker JC, Perry KW, Molloy BB (1975) Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism. Neuropharmacology 14:739-746
6. Marona D, Rhee G, Sprague JE, Nichols DE (1995) Psychostimulant-like effects of p-fluoroamphetamine in the rat. Eur J Pharmacol 287:105-113
7. Nagai F, Nonaka R, Satoh H, Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132-137
8. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848-854
9. Europol drugs newsletter (2009) Alert 2009-001, Project SYNERGY, 4-fluoroamphetamine (EDOCF403292)1. http://ewsd.wiv-isp.be/ Publicationsonnewpsychoactivesubstances/4-Fluoramphetamine/EuropolDrugsUnit- Newsletter2009-001.pdf
10. EMCDDA-Europol (2009) Annual report on the implementation of Council Decision 2005/387/JHA. (https://www.europol.europa.eu/sites/default/files/ publications/emcdda-europol-Annual-report-2009.pdf)
11. Johansen SS, Hansen TM (2012) Isomers of fluoroamphetamines detected in forensic cases in Denmark. Int J Legal Med 126:541-547
12. Camilleri A, Johnston MR, Brennan M, Davis S, Caldicott D (2010) Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci Int 197:59-66
13. Seto T, Takahashi M, Nagashima M, Suzuki J, Yasuda I (2005) The identification and the aspects of the commercially available uncontrolled drugs purchased between Apr. 2003 and Mar. 2004. Ann Rep Tokyo Metr Inst P H 56:75-80 (in Japanese)
14. Nagashima M, Seto T, Takahashi M, Suzuki J, Yasuda I (2006) Spectrum data of the 3rd governor-designated drugs and the analyses of uncontrolled drugs purchased Apr. 2005-Mar. 2006. Ann Rep Tokyo Metr Inst P H 57:109-113 (in Japanese)
15. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2008) Analysis of designer drugs detected in the products purchased in fiscal year 2006. Yakugaku Zasshi 128:1499-1505 (in Japanese)
16. Uchiyama N, Miyazawa N, Kawamura M, Kikura-Hanajiri R, Goda Y (2010) Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008. Yakugaku Zasshi 130:263-270 (in Japanese)
17. Yii-Kauhaluoma J, Vahermo M, Suominen T, Leinonen A (2009) Synthesis and characterization of hydroxylated mesocarb metabolites for doping control. Arch Pharm Life Sci 342:201-209
18. Shulgin AT, Shulgin A (1991) PIHKAL: a chemical love story. Transform Press, Berkeley
19. Rösner P, Quednow B, Girreser U, Junge T (2005) Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs). Forensic Sci Int 148:143-156
20. Westphal F, Rösner P, Junge Th (2010) Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry. Forensic Sci Int 194:53-59